Wesley T O'Neal1, Lin Y Chen2, Saman Nazarian3, Elsayed Z Soliman4. 1. Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, GA, USA. Electronic address: wesley.oneal@emory.edu. 2. Department of Medicine, Division of Cardiology, University of Minnesota Medical School, Minneapolis, MN, USA. 3. Department of Medicine, Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. 4. Department of Internal Medicine, Section on Cardiology, Wake Forest School of Medicine, Winston-Salem, NC, USA; Epidemiological Cardiology Research Center (EPICARE), Department of Epidemiology and Prevention, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Abstract
BACKGROUND: Normative values for heart rate variability (HRV) measures from 10-s electrocardiograms (ECG) have not been defined. METHODS: We reported borderline abnormal (<5th percentile) and abnormal (<2nd percentile) values of standard deviation of all normal-to-normal R-R intervals (SDNN) and root mean square of successive differences between normal-to-normal R-R intervals (rMSSD) from 10-s ECGs in 1175 participants (mean age=59±10; 59% female; 47% white) ≥45years of age from the Multi-Ethnic Study of Atherosclerosis (MESA) who were free of cardiovascular disease (CVD) and CVD risk factors. We validated the prognostic significance of these measures in a subset of the MESA cohort with complete data. RESULTS: Borderline abnormal and abnormal SDNN and rMSSD varied by sex and race. Borderline abnormal and abnormal SDNN and rMSSD were associated with an increased risk of CVD and all-cause mortality. CONCLUSIONS: The references ranges provided in this report will guide future research using these common HRV parameters.
BACKGROUND: Normative values for heart rate variability (HRV) measures from 10-s electrocardiograms (ECG) have not been defined. METHODS: We reported borderline abnormal (<5th percentile) and abnormal (<2nd percentile) values of standard deviation of all normal-to-normal R-R intervals (SDNN) and root mean square of successive differences between normal-to-normal R-R intervals (rMSSD) from 10-s ECGs in 1175 participants (mean age=59±10; 59% female; 47% white) ≥45years of age from the Multi-Ethnic Study of Atherosclerosis (MESA) who were free of cardiovascular disease (CVD) and CVD risk factors. We validated the prognostic significance of these measures in a subset of the MESA cohort with complete data. RESULTS: Borderline abnormal and abnormal SDNN and rMSSD varied by sex and race. Borderline abnormal and abnormal SDNN and rMSSD were associated with an increased risk of CVD and all-cause mortality. CONCLUSIONS: The references ranges provided in this report will guide future research using these common HRV parameters.
Authors: Paul E Drawz; Denise C Babineau; Carolyn Brecklin; Jiang He; Radhakrishna R Kallem; Elsayed Z Soliman; Dawei Xie; Dina Appleby; Amanda H Anderson; Mahboob Rahman Journal: Am J Nephrol Date: 2013-12-14 Impact factor: 3.754
Authors: Mercedes R Carnethon; Ronald J Prineas; Marinella Temprosa; Zhu-Ming Zhang; Gabriel Uwaifo; Mark E Molitch Journal: Diabetes Care Date: 2006-04 Impact factor: 19.112
Authors: David A Bluemke; Richard A Kronmal; João A C Lima; Kiang Liu; Jean Olson; Gregory L Burke; Aaron R Folsom Journal: J Am Coll Cardiol Date: 2008-12-16 Impact factor: 24.094
Authors: Emily B Schroeder; Eric A Whitsel; Gregory W Evans; Ronald J Prineas; Lloyd E Chambless; Gerardo Heiss Journal: J Electrocardiol Date: 2004-07 Impact factor: 1.438
Authors: Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy Journal: Am J Epidemiol Date: 2002-11-01 Impact factor: 4.897
Authors: M Loretto Munoz; Arie van Roon; Harriëtte Riese; Chris Thio; Emma Oostenbroek; Iris Westrik; Eco J C de Geus; Ron Gansevoort; Joop Lefrandt; Ilja M Nolte; Harold Snieder Journal: PLoS One Date: 2015-09-28 Impact factor: 3.240
Authors: Kieren J Mather; Ionut Bebu; Chelsea Baker; Robert M Cohen; Jill P Crandall; Cyrus DeSouza; Jennifer B Green; M Sue Kirkman; Heidi Krause-Steinrauf; Mary Larkin; Jeremy Pettus; Elizabeth R Seaquist; Elsayed Z Soliman; Emily B Schroeder; Deborah J Wexler; Rodica Pop-Busui Journal: Diabetes Res Clin Pract Date: 2020-05-23 Impact factor: 5.602
Authors: Joshua I Barzilay; Alokananda Ghosh; Rodica Pop Busui; Andrew Ahmann; Ashok Balasubramanyam; Mary Ann Banerji; Robert M Cohen; Jennifer Green; Faramarz Ismail-Beigi; Catherine L Martin; Elizabeth Seaquist; José A Luchsinger Journal: J Diabetes Complications Date: 2021-09-15 Impact factor: 2.852
Authors: Arnaud D Kaze; Matthew F Yuyun; Sebhat Erqou; Gregg C Fonarow; Justin B Echouffo-Tcheugui Journal: J Clin Endocrinol Metab Date: 2022-06-16 Impact factor: 6.134
Authors: Adina Zeki Al Hazzouri; Tali Elfassy; Mercedes R Carnethon; Donald M Lloyd-Jones; Kristine Yaffe Journal: Am J Hypertens Date: 2017-12-08 Impact factor: 3.080
Authors: Madalena D Costa; Susan Redline; Roger B Davis; Susan R Heckbert; Elsayed Z Soliman; Ary L Goldberger Journal: Front Physiol Date: 2018-09-03 Impact factor: 4.566
Authors: Hendrika G van Lier; Marcel E Pieterse; Ainara Garde; Marloes G Postel; Hein A de Haan; Miriam M R Vollenbroek-Hutten; Jan Maarten Schraagen; Matthijs L Noordzij Journal: Behav Res Methods Date: 2020-04
Authors: Marten E van den Berg; Peter R Rijnbeek; Maartje N Niemeijer; Albert Hofman; Gerard van Herpen; Michiel L Bots; Hans Hillege; Cees A Swenne; Mark Eijgelsheim; Bruno H Stricker; Jan A Kors Journal: Front Physiol Date: 2018-04-27 Impact factor: 4.566
Authors: Christopher L Schaich; Diego Malaver; Haiying Chen; Hossam A Shaltout; Adina Zeki Al Hazzouri; David M Herrington; Timothy M Hughes Journal: J Am Heart Assoc Date: 2020-03-21 Impact factor: 5.501